Authors
Latest:
Short-Term and Long-Term Impact of COVID-19 on Community PharmacyWhether it be delivery options, remote pharmacy, increasing roles for pharmacists and technicians, or fluctuating patient volume, the impact of COVID-19 can be felt in community pharmacies across the United States.
Latest:
Hybrid Models Can Transform Team ChemistryMorristown Medical Center’s area-based pharmacist program leads to an increase in direct patient contact and opportunities for interventions.
Latest:
Combination Shows Promise for Treating Advanced Non Small Cell Lung CancerCombining pegilodecakin (AM0010) with nivolumab (Opdivo) or pembrolizumab (Keytruda) induced an overall response rate (ORR) of 41% in patients with advanced non–small cell lung cancer (NSCLC), according to findings from an early phase study presented at the 2018 ASCO Annual meeting.
Latest:
A Population-Based Approach to Improving Patient Safety Related to Drug—Drug InteractionsSome medication combinations are a source of preventable drug-related harm. A multifaceted approach is needed to address this quality-of-care issue.
Latest:
Determinants of Primary Nonadherence in Asthma-Controller and Dyslipidemia PharmacotherapyThis study linked e-prescribing records to paid pharmacy claims to identify primary nonadherence rates and factors associated with unfilled prescriptions.
Latest:
Defining the Teriparatide Patient: Osteoporosis Sequence of Care and Healthcare ResourcesThis study provides real-world evidence of a teriparatide (TPTD) patient’s characteristics, sequence of care, and healthcare resource utilization, and compares TPTD patients with non-TPTD patients.
Latest:
Apixaban: A New Treatment Option for Cancer-Associated VTEOptimizing the best pharmaceutical agent while minimizing adverse effects is paramount in patients with cancer-associated venous thromboembolism.
Latest:
NASP Meeting Shines Light on Challenges, Opportunities in Specialty PharmacyNASP maintains a strong focus on policies affecting the national, legislative, and regulatory landscape of specialty pharmacy year round.
Latest:
Utilization Impacts of New Oral Substitutes for Parenteral Cancer-Related TherapiesExamination of changes in utilization, dose adequacy, and duration associated with market entry of the oral chelator deferasirox as a potential substitute for parenteral deferoxamine.
Latest:
Value-Based Contracts and Health Systems Specialty Pharmacy Integration: 2 Key Insights From Asembia 2017The summit provides a place for specialty pharmacy stakeholders to discuss the industry.
Latest:
Rapid Deployment of Prior Authorization PoliciesIn an effort to minimize the cost curve, payers have been adjusting their utilization management policies, spurred by the approval of several costly new hepatitis C medications.
Latest:
How to Manage the Symptoms of Autoimmune DiseaseAutoimmune diseases are often chronic conditions that can evolve, so minimizing damage and progression is typically the mainstay of treatment.
Latest:
Chaotic Health Care Landscape Breeds Opportunity for PharmacistsIn the current chaotic environment of reimbursement that depends on quality and cost savings, pharmacists should increase their presence.
Latest:
Delivering on the Potential of the Specialty Pipeline: 3 Disruptive Trends in Specialty PharmacyPharmacy stakeholders must be nimble and responsive to innovations and disruptive trends in the market.
Latest:
Rare Pharmacy Emerges From Specialty, Part 3The series concludes looking at the proposition that patients with rare and devastating disorders require and deserve a higher acuity of care and service that only an accredited rare pharmacy can deliver.
Latest:
New ACT Program Brings Challenges and BarriersBoise VA Medical Center in Idaho develops an accuracy checking technician service and shares lessons from the implementation.
Latest:
Budget Impact of Everolimus in Treating Metastatic Renal Cell CarcinomaA decision-analytical model shows that everolimus has a favorable budget impact when introduced into the treatment algorithm for metastatic renal cell carcinoma.
Latest:
Fostering Rapid Innovation During a Time of CrisisPromoting an environment that allows for rapid problem-solving and execution under high stress is essential to face problems that are poorly understood and yet require rapid change.
Latest:
Efficacy of Ezetimibe 2.5 mg With a Novel Tablet-Splitting StrategyThis prospective randomized study suggests that ezetimibe 2.5 mg, delivered as an ezetimibe/simvastatin tablet split into 4 parts, is clinically equivalent to a 10-mg dose.
Latest:
Establishing Standards of Care for Amiodarone Monitoring in an Outpatient SettingImplementing a quality-improvement project that allows for education and interdisciplinary collaboration among pharmacists, cardiologists, and primary care providers can improve rates of amiodarone monitoring.
Latest:
Summary of Current SARS-CoV-2 Vaccine TrialsMany clinical trials are underway in a race to develop a safe and effective vaccine against severe acute respiratory SARS-CoV-2, the virus that causes COVID-19.
Latest:
Therapeutic Substitution From Atorvastatin to Simvastatin: Impact on LDL ControlEvaluation of a therapeutic substitution from atorvastatin to simvastatin on low-density lipoprotein control, and assessment of program participation rates for a commercially insured population.
Latest:
E-Prescribing With Decision Support Is Associated With Improvements in Medication AdherenceThis study evaluates whether provider adoption and use of formulary decision support for e-prescribing are directly associated with significant prescriber and patient behavior change.
Latest:
An Introduction to Pharmaceutical Industry FellowshipsWith the current increase in pharmacy school enrollment contributing to a more competitive job market, novel and nontraditional career paths may become a more viable option for pharmacy school graduates.
